вторник, 31 января 2017 г.

Supreme Court to Consider BPCIA Requirements for Biosimilars

Supreme Court to Consider BPCIA Requirements for Biosimilars


The Supreme Court of the United States has granted certiorari in a case involving the Biologics Price Competition and Innovation Act of 2009 in the context of a biosimilars dispute. Sandoz, Inc. v.



from Biotech News